Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedJul 06, 2025
DataAggregated Company Financials
Companies54
  • 7D-1.5%
  • 3M10.5%
  • 1Y-10.1%
  • YTDn/a

Over the last 7 days, the Pharma industry has dropped 1.5%, driven by Bora Pharmaceuticals declining 3.3%. The industry has fallen 10% in the last year. Looking forward, earnings are forecast to grow by 50% annually.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 07 Jul 2025NT$669.3bNT$116.0bNT$14.3b18.7x46.8x5.8x
Wed, 04 Jun 2025NT$610.1bNT$115.9bNT$14.3b18.8x42.8x5.3x
Fri, 02 May 2025NT$557.0bNT$113.3bNT$10.6b18.7x52.5x4.9x
Sun, 30 Mar 2025NT$617.9bNT$112.9bNT$10.9b18.9x56.9x5.5x
Tue, 25 Feb 2025NT$680.7bNT$109.3bNT$11.5b23.5x59.2x6.2x
Thu, 23 Jan 2025NT$612.0bNT$109.3bNT$11.4b21.7x53.5x5.6x
Sat, 21 Dec 2024NT$583.3bNT$109.3bNT$11.4b21.7x51x5.3x
Mon, 18 Nov 2024NT$620.1bNT$108.8bNT$10.1b23.6x61.7x5.7x
Wed, 16 Oct 2024NT$622.4bNT$104.7bNT$8.9b27.6x69.6x5.9x
Fri, 13 Sep 2024NT$635.4bNT$104.7bNT$8.9b25.4x71.1x6.1x
Sun, 11 Aug 2024NT$629.0bNT$101.2bNT$7.1b28.7x88.7x6.2x
Tue, 09 Jul 2024NT$711.4bNT$100.5bNT$6.8b32.7x104.2x7.1x
Thu, 06 Jun 2024NT$638.9bNT$100.4bNT$7.1b29.5x89.4x6.4x
Sat, 04 May 2024NT$619.1bNT$101.8bNT$9.4b24.9x66.2x6.1x
Mon, 01 Apr 2024NT$646.3bNT$101.2bNT$9.2b26.6x70.1x6.4x
Wed, 28 Feb 2024NT$658.2bNT$101.6bNT$8.2b24.6x80.2x6.5x
Fri, 26 Jan 2024NT$588.9bNT$101.9bNT$7.8b23.7x75.6x5.8x
Sun, 24 Dec 2023NT$580.6bNT$101.6bNT$7.6b23.4x76.1x5.7x
Tue, 21 Nov 2023NT$563.8bNT$101.8bNT$8.4b24.5x67.3x5.5x
Thu, 19 Oct 2023NT$520.3bNT$101.7bNT$9.6b20.1x54.1x5.1x
Sat, 16 Sep 2023NT$555.6bNT$101.7bNT$9.6b22.8x57.7x5.5x
Mon, 14 Aug 2023NT$556.9bNT$97.7bNT$7.9b19.9x70.1x5.7x
Wed, 12 Jul 2023NT$576.1bNT$98.7bNT$10.1b17x57.2x5.8x
Fri, 09 Jun 2023NT$578.5bNT$98.6bNT$10.1b16.8x57.5x5.9x
Sun, 07 May 2023NT$584.4bNT$92.1bNT$8.6b22.3x68.1x6.3x
Tue, 04 Apr 2023NT$569.0bNT$91.5bNT$8.7b20.7x65.8x6.2x
Thu, 02 Mar 2023NT$553.7bNT$84.7bNT$7.6b23.5x72.5x6.5x
Sat, 28 Jan 2023NT$484.3bNT$84.6bNT$7.9b20.6x61.4x5.7x
Mon, 26 Dec 2022NT$505.4bNT$84.6bNT$7.9b23.1x64.1x6x
Wed, 23 Nov 2022NT$452.9bNT$84.6bNT$7.7b16.2x58.8x5.4x
Fri, 21 Oct 2022NT$404.6bNT$78.9bNT$4.3b17x93.5x5.1x
Sun, 18 Sep 2022NT$459.4bNT$78.9bNT$4.3b18.4x106.2x5.8x
Tue, 16 Aug 2022NT$398.5bNT$79.0bNT$5.1b18.4x78.7x5x
Thu, 14 Jul 2022NT$379.8bNT$76.8bNT$4.4b21.4x86.9x4.9x
Price to Earnings Ratio

86.9x


Total Market Cap: NT$379.8bTotal Earnings: NT$4.4bTotal Revenue: NT$76.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 68.8x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 47.5x which is lower than its 3-year average PE of 68.9x.
  • The industry is trading close to its 3-year average PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 48% per year over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Taiwanese Pharma compare with similar industries?

TW Market-0.27%
Healthcare-2.25%
Pharma-1.52%
Pharma-1.52%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6576 Foresee PharmaceuticalsNT$66.304.1%
+NT$402.6m		-21.7%PS24.1x
7754 AnnJi PharmaceuticalNT$25.2012.5%
+NT$262.9m		-45.5%PS24.5x
6876 LAUNXP BiomedicalNT$23.5030.2%
+NT$176.9m		-14.1%n/a
4114 Synmosa BiopharmaNT$36.901.0%
+NT$159.3m		1.5%PE23.7x
7759 Sunhawk Vision BiotechNT$84.501.8%
+NT$105.1m		n/aPB20x

Latest News

4114
NT$36.90
Synmosa Biopharma
7D
1.0%
1Y
1.5%
6576
NT$66.30
Foresee Pharmaceuticals
7D
4.1%
1Y
-21.7%
6620
NT$79.30
Handa Pharmaceuticals
7D
-5.4%
1Y
-23.0%
4747
NT$64.90
Johnson Chemical Pharmaceutical Works
7D
3.2%
1Y
-8.8%
6935
NT$26.30
Prince Pharmaceutical
7D
7.6%
1Y
-8.7%
6472
NT$781.00
Bora Pharmaceuticals
7D
-6.0%
1Y
-12.9%
6838
NT$34.70
Formosa Pharmaceuticals
7D
-6.0%
1Y
-36.3%
4743
NT$60.30
Oneness Biotech
7D
-6.4%
1Y
-60.2%
7754
NT$25.20
AnnJi Pharmaceutical
7D
12.5%
1Y
-45.5%
6919
NT$1,235.00
Caliway Biopharmaceuticals
7D
-8.2%
1Y
70.1%
4123
NT$36.85
Center Laboratories
7D
-3.2%
1Y
-36.0%
1795
NT$214.00
Lotus Pharmaceutical
7D
-3.4%
1Y
-30.7%
6535
NT$140.50
Lumosa Therapeutics
7D
-4.1%
1Y
-32.9%
6709
NT$21.70
Advagene Biopharma
7D
5.3%
1Y
-2.3%
7759
NT$84.50
Sunhawk Vision Biotech
7D
1.8%
1Y
n/a
6876
NT$23.50
LAUNXP Biomedical
7D
30.2%
1Y
-14.1%